The Trump administration has launched TrumpRx.gov, a federal website intended to help consumers find cash-pay discounts on brand-name prescription drugs. The site went live Thursday evening listing 43 drugs from five manufacturers that struck deals with the administration: AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer. The White House said discounts from 11 additional companies will be added in coming months.
President Trump hailed the rollout as “the biggest thing to happen in health care, I think, in many, many decades.” Discount levels on the site vary widely; examples published at launch include roughly 33% off Pfizer’s Xeljanz, used for autoimmune conditions, and about 93% off EMD Serono’s Cetrotide, used in fertility treatment.
To claim some offers, users must affirm they are not enrolled in a government insurance program such as Medicare and that they will not seek insurance reimbursement or credit the out-of-pocket cost toward a deductible. After confirming eligibility, users can obtain a coupon to present at participating pharmacies. Some discounts direct customers to a drugmaker’s own website for additional steps — for example, the listing for AstraZeneca’s Bevespi inhaler points shoppers to the company site.
The TrumpRx initiative stems from agreements announced last fall in which drugmakers, in exchange for exemptions from certain tariffs, agreed to lower some Medicaid prices, to price future drugs no higher than in other wealthy countries, and to offer cash-pay discounts through the TrumpRx portal.
Drug policy experts say the program is likely to help only a limited number of patients. Dr. Ben Rome, a health policy researcher at Brigham and Women’s Hospital, said the site “has undergone a lot of hype,” adding that for most insured patients it will remain cheaper to use insurance and pay co-pays than to pay cash even at discounted rates. The TrumpRx materials similarly advise insured shoppers to check their co-pays before paying cash.
Some drugs listed on TrumpRx are already available as low-cost generics. For example, Protonix appears on the site at about $200, while the generic pantoprazole can be found for roughly $30 with a GoodRx coupon. Still, cash-pay discounts can matter for patients whose medicines are not covered by insurance — such as certain fertility or obesity treatments — and price-shopping across platforms like TrumpRx, GoodRx, Mark Cuban’s Cost Plus Drugs, or large retailers such as Costco may yield better deals.
TrumpRx’s current list resembles offerings on established discount platforms; GoodRx said it is a “key integration partner” providing pricing to the new site. The rollout has also drawn legal scrutiny: on Jan. 29, three Senate Democrats sent a letter to the Department of Health and Human Services inspector general asking whether TrumpRx and related direct-to-consumer platforms comply with federal law, citing potential illegal kickbacks, conflicts of interest and risks of unnecessary medication use.